Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Mar;49(3):143–146. doi: 10.1136/ard.49.3.143

DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.

D P Singal 1, B Reid 1, D Green 1, W G Bensen 1, M D'Souza 1
PMCID: PMC1004007  PMID: 1969727

Abstract

A strong association between HLA-DR4 and rheumatoid arthritis (RA) has been found in a number of populations. In contrast, the incidence of DR2 is decreased in patients with RA, suggesting that this specificity may confer some protection against the disease. A number of subtypes of DR2 have been defined by serology, by responses in mixed lymphocyte culture reaction, and, more recently, by restriction fragment length polymorphism. These subtypes of DR2 are in linkage disequilibrium with different subspecificities of DQw1. It is thus likely that the distribution of these subtypic DR,DQ haplotypes in DR2 positive patients with RA may be important in understanding the genetic basis of susceptibility/resistance to RA. In this paper a study of the subtypes of DR2,DQw1 haplotypes in 18 patients with RA, who required sodium aurothiomalate as a disease remitting drug, and unrelated healthy individuals is reported. Three subtypes of DR2 haplotypes, DRw15 (Dw2),DQw1.2(DQw6), DRw15(Dw12),DQw1.12(DQw6), and DRw16(Dw21),DQw1, AZH (DQw5), were analysed with a cDNA probe for the DQ beta gene. The data show that DR2 positive patients with RA carried either the DRw15(Dw2),DQw6 or DRw15(Dw12),DQw6 haplotype. No patient with RA was positive for the DRw16(Dw21),DQw5 subspecificity. In contrast, six of 29 (21%) normal healthy DR2,DQw1 positive individuals carried the DRw16(Dw21),DQw5 haplotype. These data together with earlier results on the distribution of the DR4,DQw7 haplotype in patients with RA support the hypothesis that DQB1 chain polymorphism may be important in determining susceptibility to severe RA.

Full text

PDF
143

Images in this article

144Image
on p.144
144Image
on p.144
145Image
on p.145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., Rich S. S., Barbosa J., Segall M. Insulin-dependent diabetes--associated HLA-D region encoded determinants. Hum Immunol. 1985 Feb;12(2):59–64. doi: 10.1016/0198-8859(85)90343-x. [DOI] [PubMed] [Google Scholar]
  2. Brautbar C., Naparstek Y., Yaron M., Amar A., Ehrenfeld M., Eliakim M., Bentwich Z., Cohen T., Korman S. H., Albert E. D. Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens. 1986 Jul;28(1):8–14. doi: 10.1111/j.1399-0039.1986.tb00454.x. [DOI] [PubMed] [Google Scholar]
  3. Cohen D., Cohen O., Marcadet A., Massart C., Lathrop M., Deschamps I., Hors J., Schuller E., Dausset J. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1774–1778. doi: 10.1073/pnas.81.6.1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen N., Amar A., Oksenberg J. R., Brautbar C. HLA-D clusters associated with DR2 and the definition of HLA-D"AZH": a new DR2 related HLA-D specificity in Israel. Tissue Antigens. 1984 Jul;24(1):1–9. doi: 10.1111/j.1399-0039.1984.tb00390.x. [DOI] [PubMed] [Google Scholar]
  5. Cohen N., Brautbar C., Font M. P., Dausset J., Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics. 1986;23(2):84–89. doi: 10.1007/BF00377966. [DOI] [PubMed] [Google Scholar]
  6. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  7. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov;30(11):1205–1213. doi: 10.1002/art.1780301102. [DOI] [PubMed] [Google Scholar]
  8. Grennan D. M., Dyer P. A. Immunogenetics and rheumatoid arthritis. Immunol Today. 1988 Feb;9(2):33–35. doi: 10.1016/0167-5699(88)91249-2. [DOI] [PubMed] [Google Scholar]
  9. Honda Y., Juji T., Matsuki K., Naohara T., Satake M., Inoko H., Someya T., Harada S., Doi Y. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep. 1986;9(1 Pt 2):133–142. doi: 10.1093/sleep/9.1.133. [DOI] [PubMed] [Google Scholar]
  10. Hyperprolactinaemia; when is a prolactinoma not a prolactinoma? Lancet. 1987 Oct 31;2(8566):1002–1004. [PubMed] [Google Scholar]
  11. Jacobson S., Nepom G. T., Richert J. R., Biddison W. E., McFarland H. F. Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones. J Exp Med. 1985 Jan 1;161(1):263–268. doi: 10.1084/jem.161.1.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jacobson S., Sorrentino R., Nepom G. T., McFarlin D. E., Strominger J. L. DNA restriction fragment length polymorphism of HLA-DR2: correlation with HLA-DR2-associated functions. J Neuroimmunol. 1986 Sep;12(3):195–203. doi: 10.1016/s0165-5728(86)80003-0. [DOI] [PubMed] [Google Scholar]
  13. Jaraquemada D., Ollier W., Awad J., Young A., Silman A., Roitt I. M., Corbett M., Hay F., Cosh J. A., Maini R. N. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis. 1986 Aug;45(8):627–636. doi: 10.1136/ard.45.8.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Larhammar D., Schenning L., Gustafsson K., Wiman K., Claesson L., Rask L., Peterson P. A. Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3687–3691. doi: 10.1073/pnas.79.12.3687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lechler R. I., Ronchese F., Braunstein N. S., Germain R. N. I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer. J Exp Med. 1986 Mar 1;163(3):678–696. doi: 10.1084/jem.163.3.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marcadet A., Gebuhrer L., Betuel H., Seignalet J., Freidel A. C., Confavreux C., Billiard M., Dausset J., Cohen D. DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immunogenetics. 1985;22(6):679–683. doi: 10.1007/BF00430317. [DOI] [PubMed] [Google Scholar]
  17. Matsuki K., Maeda H., Juji T., Inoko H., Ando A., Tsuji K., Honda Y. Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy. Immunogenetics. 1988;27(2):87–90. doi: 10.1007/BF00351080. [DOI] [PubMed] [Google Scholar]
  18. McCusker C. T., Singal D. P. Molecular relationships between the class II HLA antigens and susceptibility to rheumatoid arthritis. J Rheumatol. 1988 Jul;15(7):1050–1053. [PubMed] [Google Scholar]
  19. Nepom B. S., Palmer J., Kim S. J., Hansen J. A., Holbeck S. L., Nepom G. T. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med. 1986 Jul 1;164(1):345–350. doi: 10.1084/jem.164.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nepom G. T., Hansen J. A., Nepom B. S. The molecular basis for HLA class II associations with rheumatoid arthritis. J Clin Immunol. 1987 Jan;7(1):1–7. doi: 10.1007/BF00915418. [DOI] [PubMed] [Google Scholar]
  21. Ohta N., Nishimura Y. K., Tanimoto K., Horiuchi Y., Abe C., Shiokawa Y., Abe T., Katagiri M., Yoshiki T., Sasazuki T. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol. 1982 Oct;5(2):123–132. doi: 10.1016/0198-8859(82)90057-x. [DOI] [PubMed] [Google Scholar]
  22. Olsen N. J., Callahan L. F., Brooks R. H., Nance E. P., Kaye J. J., Stastny P., Pincus T. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med. 1988 Feb;84(2):257–264. doi: 10.1016/0002-9343(88)90422-6. [DOI] [PubMed] [Google Scholar]
  23. Reinsmoen N. L., Layrisse Z., Betuel H., Freidel A. C., Bach F. H. A study of HLA-DR2 associated HLA-Dw/LD specificities. Hum Immunol. 1984 Oct;11(2):105–115. doi: 10.1016/0198-8859(84)90049-1. [DOI] [PubMed] [Google Scholar]
  24. Rosenshine S., Cascino I., Zeevi A., Duquesnoy R. J., Trucco M. DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones. Immunogenetics. 1986;23(3):187–196. doi: 10.1007/BF00373820. [DOI] [PubMed] [Google Scholar]
  25. Sansom D. M., Bidwell J. L., Klouda P. T., Amin S. N., Bradley B. A., Maddison P. J. HLA DQ Polymorphism in rheumatoid arthritis. Lancet. 1988 Jan 2;1(8575-6):58–59. doi: 10.1016/s0140-6736(88)91039-2. [DOI] [PubMed] [Google Scholar]
  26. Schiff B., Mizrachi Y., Orgad S., Yaron M., Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis. 1982 Aug;41(4):403–404. doi: 10.1136/ard.41.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Segall M., Noreen H., Schluender L., Bach F. H. DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2. Hum Immunol. 1986 Mar;15(3):336–343. doi: 10.1016/0198-8859(86)90009-1. [DOI] [PubMed] [Google Scholar]
  28. Singal D. P., Bensen W. G., Kassam Y. B. HLA-DQ polymorphism in rheumatoid arthritis. Lancet. 1988 Mar 5;1(8584):529–529. doi: 10.1016/s0140-6736(88)91315-3. [DOI] [PubMed] [Google Scholar]
  29. Singal D. P., Butler L., Lamontagne L. Identification of two subtypes of HLA-DR2 by Southern blot analysis. Tissue Antigens. 1986 Jul;28(1):29–40. doi: 10.1111/j.1399-0039.1986.tb00457.x. [DOI] [PubMed] [Google Scholar]
  30. Singal D. P., D'Souza M., Butler L. Heterogeneity of HLA-DR2: definition of two subtypes by serological and cellular techniques. Tissue Antigens. 1985 May;25(5):283–289. doi: 10.1111/j.1399-0039.1985.tb00451.x. [DOI] [PubMed] [Google Scholar]
  31. Singal D. P., D'Souza M., Reid B., Bensen W. G., Kassam Y. B., Adachi J. D. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet. 1987 Nov 14;2(8568):1118–1120. doi: 10.1016/s0140-6736(87)91548-0. [DOI] [PubMed] [Google Scholar]
  32. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  33. Stastny P., Ball E. J., Khan M. A., Olsen N. J., Pincus T., Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol. 1988;27 (Suppl 2):132–138. doi: 10.1093/rheumatology/xxvii.suppl_2.132. [DOI] [PubMed] [Google Scholar]
  34. Wallin J., Carlsson B., Ström H., Möller E. A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum. 1988 Jan;31(1):72–79. doi: 10.1002/art.1780310111. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES